Heart Disease

Home/Tag: Heart Disease

SLU Researchers Discover Structure of Protein Associated with Inflammation, Parkinson’s

In a recent paper published in Nature Communications, Saint Louis University scientists report that they have determined the structure of a key protein that is involved in the body’s inflammatory response. This finding opens the door to developing new treatments for a wide range of illnesses, from heart disease, diabetes and cancer to neurodegenerative disorders, including

High Salt Intake Linked to Increased Heart-Failure Risk

BARCELONA, SPAIN — High daily salt intake is associated with a substantial increase in an individual's risk of developing heart failure, independent of other risk factors, suggests one of the largest studies to accurately measure salt consumption[1]. The analysis of more than 4500 individuals, presented here at the European Society of Cardiology (ESC) 2017 Congress, indicated

September 12th, 2017|Categories: Disease Specific, Heart Disease|Tags: , |

Micro heart muscle created from stem cells

Posted: Apr 21, 2016   (Nanowerk News) Scientists at the Gladstone Institutes have invented a new way to create three-dimensional human heart tissue from stem cells ("Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses"). The tissue can be used to model disease and test drugs, and it opens the door for a precision

Stem cell therapy ‘halves number of heart failure deaths’

April 11, 2016 Spectator Health reporter Injecting adult stem cells into the heart could potentially halve the number of deaths from heart failure, a study has suggested. The study, published in the Lancet, found that patients who received the treatment had a 37 per cent lower rate of death and hospitalisation for heart failure-related problems.

Study Showing How Stem Cells Slow Aging May Lead to New Heart Failure Treatments

DURHAM, N.C., April 8, 2015 /PRNewswire/ -- A new study published in STEM CELLS Translational Medicine demonstrates how mesenchymal stem cells (MSCs) not only protect the heart from further damage after a cardiac incident but can actually slow down its aging process, too. These findings, in a rat model of the aging heart, could help propel stem

How Vitamin D May Affect Heart Disease, Diabetes

March 30, 2015 At a Glance Mice with immune cells unable to use vitamin D developed atherosclerosis and insulin resistance, precursors of heart disease and type 2 diabetes. The mechanisms uncovered may lead to novel therapies. The findings also suggest that vitamin D might help prevent the complications of diabetes and inflammation. Vitamin D deficiency

Study shows who benefits most from statins

March 3, 2015 By Julia Evangelou Strait ROBERT BOSTON Nathan O. Stitziel, MD, PhD, a Washington University cardiologist and human geneticist, is co-first author on a study that suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. New research suggests that widely used statin

Bioengineered miniature structures could prevent heart failure

Feb. 4, 2015 Medical College of Wisconsin The delivery of tiny biodegradable microstructures to heart tissue damaged by heart attack may help repair the tissue and prevent future heart failure. A team led by cardiovascular researchers at the Medical College of Wisconsin (MCW) bioengineered the microstructures to be the same size, shape and stiffness as

Errors in single gene may protect against heart disease

Washington University in St. Louis, by Julia Evangelou Strait ~ November 12, 2014 Rare mutations that shut down a single gene are linked to lower cholesterol levels and a 50 percent reduction in the risk of heart attack, according to new research from Washington University School of Medicine in St. Louis, the Broad Institute at

Cedars-Sinai Heart Institute launches stem cell therapy research clinic for cardiac patients

The Heart Institute Regenerative Medicine Clinic, will evaluate the potential benefits of stem cells for the repair of diseased or damaged CV tissue and match patients with appropriate clinical trials. The clinic is the first of its kind within a major US academic medical center, according to a press release. Eduardo Marbán, MD, PhD, director